Single-incision laparoscopic ileal pouch-anal anastomosis in children--how does it compare to a laparoscopic-assisted

Stephanie F Polites1, Abdalla E Zarroug, Christopher R Moir

  • 11 Department of Surgery, Mayo Clinic , Rochester, Minnesota.

Insights

Single-incision laparoscopic ileal pouch-anal anastomosis (SIL IPAA) is a safe alternative to laparoscopic-assisted IPAA in children. SIL IPAA may reduce hospital stay without increasing complications for pediatric patients with chronic ulcerative colitis or familial adenomatous polyposis.

Area of Science:

  • Pediatric surgery
  • Gastrointestinal surgery
  • Minimally invasive surgery

Background:

  • Single-incision laparoscopic (SIL) ileal pouch-anal anastomosis (IPAA) feasibility and safety are established.
  • Outcomes of SIL IPAA have not been compared to standard laparoscopic-assisted (LA) IPAA.
  • Comparison is needed for pediatric patients with chronic ulcerative colitis (CUC) and familial adenomatous polyposis (FAP).

Purpose of the Study:

  • To compare SIL IPAA and LA IPAA outcomes in pediatric patients.
  • To evaluate operative time, length of stay, and complications.
  • To assess differences based on diagnosis (CUC/FAP) and number of surgical stages.

Main Methods:

  • Retrospective review of pediatric patients (≤18 years) undergoing SIL or LA IPAA (2000-2013).
  • Comparison of patient demographics, diagnoses, and surgical approaches.
  • Analysis of operative time, postoperative length of stay, and complications stratified by stage and diagnosis.

Main Results:

  • No significant differences in age, gender, diagnosis, or anastomosis technique between SIL (n=19) and LA (n=62) IPAA.
  • SIL IPAA showed shorter operative time for one-stage procedures (308 vs. 355 minutes; P<.001).
  • Median length of stay was significantly shorter for SIL IPAA (4 vs. 7 days; P<.001), particularly for two-stage procedures (4 vs. 6 days; P=.009).
  • No significant differences in postoperative complications were observed between the two approaches.

Conclusions:

  • SIL IPAA is a safe and viable alternative to LA IPAA in pediatric CUC and FAP patients.
  • SIL IPAA may lead to a reduced postoperative length of stay.
  • Further research is required to ascertain any long-term benefits of SIL IPAA.
Abstract